872363-17-2Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1LZXMUJCJAWVHPZ-UHFFFAOYSA-NDipraglurant has been used in trials studying the treatment of Parkinson's Disease. It is a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM).
872363-17-2DTXSID90236230CHEMBL2346738UsesDipraglurant (ADX48621) is a potent, selective, orally active and brain penetrant mGluR5 negative allosteric modulator (NAM), with an IC50 of 21 nM. Dipraglurant can reduce Levodopa-induced dyskinesia (LID) in vivo[1][2]. Dipraglurant is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
No reaction records under the current filter.
Loading…